Moreover, fungal meroterpenoids, hybrid polyketide-terpenoid metabolites, exhibit anti-cholinesterase and BACE1-inhibitory activity, offering promising leads for Alzheimer’s and Parkinson’s disease therapy (Dimitrova et al., 2025). The gene discussed is BACE1; the disease is Parkinson disease.